Eva‐Maria Fronk

541 total citations
19 papers, 403 citations indexed

About

Eva‐Maria Fronk is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Eva‐Maria Fronk has authored 19 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 4 papers in Hematology. Recurrent topics in Eva‐Maria Fronk's work include Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (4 papers). Eva‐Maria Fronk is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (4 papers). Eva‐Maria Fronk collaborates with scholars based in Germany, Italy and Spain. Eva‐Maria Fronk's co-authors include Andreas M. Stadelmann, Thomas Nadulski, Patrik Roser, Martin Schnelle, Fritz Pragst, Petra Laeis, Peter Bramlage, Stefan N. Willich, Rupert Bauersachs and Patrick Mismetti and has published in prestigious journals such as European Heart Journal, Thrombosis and Haemostasis and International Journal of Cardiology.

In The Last Decade

Eva‐Maria Fronk

18 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva‐Maria Fronk Germany 10 147 139 138 52 49 19 403
Sagar S Makanji United States 10 46 0.3× 40 0.3× 71 0.5× 92 1.8× 23 0.5× 20 372
David Z. Rose United States 11 95 0.6× 130 0.9× 107 0.8× 29 0.6× 31 0.6× 48 528
Simone Y. Loo Canada 7 43 0.3× 121 0.9× 214 1.6× 42 0.8× 4 0.1× 7 399
Bmy Cheung Hong Kong 9 47 0.3× 7 0.1× 152 1.1× 57 1.1× 22 0.4× 49 461
Su Shen China 9 53 0.4× 12 0.1× 43 0.3× 113 2.2× 28 0.6× 23 432
Benoît Février France 9 23 0.2× 66 0.5× 60 0.4× 121 2.3× 6 0.1× 13 383
Christian Ellermann Germany 14 23 0.2× 20 0.1× 553 4.0× 52 1.0× 23 0.5× 95 667
Bas A. in't Veld Netherlands 7 84 0.6× 5 0.0× 146 1.1× 82 1.6× 11 0.2× 7 462
L. Agerskov Andersen Denmark 5 77 0.5× 29 0.2× 84 0.6× 34 0.7× 3 0.1× 7 442
Katherine H. Saunders United States 17 246 1.7× 5 0.0× 45 0.3× 313 6.0× 14 0.3× 35 854

Countries citing papers authored by Eva‐Maria Fronk

Since Specialization
Citations

This map shows the geographic impact of Eva‐Maria Fronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva‐Maria Fronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva‐Maria Fronk more than expected).

Fields of papers citing papers by Eva‐Maria Fronk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva‐Maria Fronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva‐Maria Fronk. The network helps show where Eva‐Maria Fronk may publish in the future.

Co-authorship network of co-authors of Eva‐Maria Fronk

This figure shows the co-authorship network connecting the top 25 collaborators of Eva‐Maria Fronk. A scholar is included among the top collaborators of Eva‐Maria Fronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva‐Maria Fronk. Eva‐Maria Fronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Agnelli, Giancarlo, Ulrich Hoffmann, Pierre Hainaut, et al.. (2025). Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe. Thrombosis and Haemostasis. 125(9). 880–892. 1 indexed citations
2.
Kirchhof, Paulus, Ameet Bakhai, Carlo de Asmundis, et al.. (2024). Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study. International Journal of Cardiology. 408. 132118–132118. 1 indexed citations
3.
Kirchhof, Paulus, Ameet Bakhai, Joris R. de Groot, et al.. (2023). Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study. European Heart Journal. 44(Supplement_2).
4.
Giustozzi, Michela, Luca Valerio, Giancarlo Agnelli, et al.. (2021). Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE. European Journal of Internal Medicine. 88. 43–51. 16 indexed citations
5.
Bernthal, Nicholas M., John H. Healey, Emanuela Palmerini, et al.. (2021). The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study. Orphanet Journal of Rare Diseases. 16(1). 191–191. 32 indexed citations
6.
López‐Bastida, Julio, Isaac Aranda-Reneo, Beatriz Rodríguez-Sánchez, et al.. (2021). Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry. Orphanet Journal of Rare Diseases. 16(1). 294–294. 11 indexed citations
7.
Agnelli, Giancarlo, Ulrich Hoffmann, Pierre Hainaut, et al.. (2020). ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. Thrombosis Research. 196. 297–304. 8 indexed citations
8.
Cohen, Alexander T., Ulrich Hoffmann, Pierre Hainaut, et al.. (2020). ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries. European Journal of Internal Medicine. 82. 48–55. 5 indexed citations
9.
10.
Bauersachs, Rupert, Giancarlo Agnelli, Anselm K. Gitt, et al.. (2017). The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry. Thrombosis Research. 157. 181–188. 12 indexed citations
11.
Cohen, Alexander T., Anselm K. Gitt, Rupert Bauersachs, et al.. (2017). The management of acute venous thromboembolism in clinical practice. Thrombosis and Haemostasis. 117(7). 1326–1337. 66 indexed citations
12.
Schmieder, Roland E., et al.. (2016). Quality of life and emotional impact of a fixed‐dose combination of antihypertensive drugs in patients with uncontrolled hypertension. Journal of Clinical Hypertension. 19(2). 126–134. 8 indexed citations
13.
Agnelli, Giancarlo, Anselm K. Gitt, Rupert Bauersachs, et al.. (2015). The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry. Thrombosis Journal. 13(1). 41–41. 37 indexed citations
14.
Bramlage, Peter, et al.. (2014). Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice. Vascular Health and Risk Management. 11. 1–1. 10 indexed citations
15.
Bramlage, Peter, Reinhard G. Ketelhut, Eva‐Maria Fronk, et al.. (2014). Clinical Impact of Patient Adherence to a Fixed-Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide. Clinical Drug Investigation. 34(6). 403–411. 18 indexed citations
16.
Bramlage, Peter, et al.. (2010). Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care. Expert Opinion on Pharmacotherapy. 11(17). 2779–2790. 7 indexed citations
17.
Büssing, Arndt, et al.. (2006). Prevention of surgery-induced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients.. PubMed. 25(6C). 4753–7. 21 indexed citations
18.
19.
Büssing, Arndt, Matthias Bischof, Wolfgang Hatzmann, et al.. (2004). Beeinflussung der Granulozytenfunktion durch einmalige perioperative Mistelextrakt-Infusion. 36(4). 148–153. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sagar S Makanji Breakdown of academic impact, for papers by David Z. Rose Breakdown of academic impact, for papers by Simone Y. Loo Breakdown of academic impact, for papers by Bmy Cheung Breakdown of academic impact, for papers by Su Shen Breakdown of academic impact, for papers by Benoît Février Breakdown of academic impact, for papers by Christian Ellermann Breakdown of academic impact, for papers by Bas A. in't Veld Breakdown of academic impact, for papers by L. Agerskov Andersen Breakdown of academic impact, for papers by Katherine H. Saunders
Rankless by CCL
2026